Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome in Pregnancy

doi:10.1017/9781108975780.058

Chapter 49 - Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome in Pregnancy

from Section 8 - Connective Tissue Disorders in Pregnancy

Published online by Cambridge University Press: 23 February 2023

Oseme Etomi and

Catherine Nelson-Piercy

Edited by

Amira El-Messidi and

Alan D. Cameron

Show author details

Amira El-Messidi: Affiliation:
McGill University, Montréal
Alan D. Cameron: Affiliation:
University of Glasgow

Book contents

Get access

Summary

A 28-year-old nulligravida is referred by her primary care provider to your high-risk obstetrics clinic for preconception counseling for known systemic lupus erythematosus (SLE).

Keywords

Preconception counseling Systemic lupus erythematosus (SLE)Antiphospholipid antibody syndrome (APLAS)Catastrophic APLAS Comorbidities Immune features Pharmacology, treatment, hydroxychloroquine, heparins Preeclampsia, low-dose aspirin, vitamin D Drug-induced lupus Perinatal risks, complications, maternal-fetal morbidity, adverse outcome Investigations, prenatal Preconception counselling Flare, antenatal Neonatal lupus syndrome Neonatal cutaneous lupus syndrome Congenital heart block Contraception

Type: Chapter
Information: OSCEs in Obstetrics and Maternal-Fetal Medicine
An Evidence-Based Approach
, pp. 619 - 634

DOI: https://doi.org/10.1017/9781108975780.058 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Suggested Readings

Andreoli, L, Bertsias, GK, Agmon-Levin, N, et al. EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017;76(3):476–485.CrossRef Google Scholar PubMed

Do, SC, Druzin, ML. Systemic lupus erythematosus in pregnancy: high risk, high reward. Curr Opin Obstet Gynecol. 2019;31(2):120–126.CrossRef Google Scholar PubMed

Flint, J, Panchal, S, Hurrell, A, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2016;55(9):1693–1697.CrossRef Google Scholar PubMed

Giles, I, Yee, CS, Gordon, C. Stratifying management of rheumatic disease for pregnancy and breastfeeding. Nat Rev Rheumatol. 2019;15(7):391–402.Google Scholar

Knight, CL, Nelson-Piercy, C. Management of systemic lupus erythematosus during pregnancy: challenges and solutions. Open Access Rheumatol. 2017;9:37–53.Google Scholar

Lazzaroni, MG, Dall’Ara, F, Fredi, M, et al. A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus. J Autoimmun. 2016;74:106–117.CrossRef Google Scholar PubMed

Nahal, SK, Selmi, C, Gershwin, ME. Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus. J Autoimmun. 2018;93:16–23.Google Scholar

Nelson-Piercy’s Handbook of Obstetric Medicine, 6th ed. London: Taylor and Francis; 2020.Google Scholar

Petri, M. Pregnancy and systemic lupus erythematosus. Best Pract Res Clin Obstet Gynaecol. 2020;64:24–30.CrossRef Google Scholar PubMed

Sammaritano, LR, Bermas, BL, Chakravarty, EE, et al. 2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 2020;72(4):529–556.Google Scholar